Literature DB >> 17459609

Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement?

Allen M Chen1, Megan E Daly, M Kara Bucci, Ping Xia, Clayton Akazawa, Jeanne M Quivey, Vivian Weinberg, Joaquin Garcia, Nancy Y Lee, Michael J Kaplan, Ivan El-Sayed, David W Eisele, Karen K Fu, Theodore L Phillips.   

Abstract

PURPOSE: To compare clinical outcomes of patients with carcinomas of the paranasal sinuses and nasal cavity according to decade of radiation treatment. METHODS AND MATERIALS: Between 1960 and 2005, 127 patients with sinonasal carcinoma underwent radiotherapy with planning and delivery techniques available at the time of treatment. Fifty-nine patients were treated by conventional radiotherapy; 45 patients by three-dimensional conformal radiotherapy; and 23 patients by intensity-modulated radiotherapy. Eighty-two patients (65%) were treated with radiotherapy after gross total tumor resection. Nineteen patients (15%) received chemotherapy. The most common histology was squamous cell carcinoma (83 patients).
RESULTS: The 5-year estimates of overall survival, local control, and disease-free survival for the entire patient population were 52%, 62%, and 54%, respectively. There were no significant differences in any of these endpoints with respect to decade of treatment or radiotherapy technique (p > 0.05, for all). The 5-year overall survival rate for patients treated in the 1960s, 1970s, 1980s, 1990s, and 2000s was 46%, 56%, 51%, 53%, and 49%, respectively (p = 0.23). The observed incidence of severe (Grade 3 or 4) late toxicity was 53%, 45%, 39%, 28%, and 16% among patients treated in the 1960s, 1970s, 1980s, 1990s, and 2000s, respectively (p = 0.01).
CONCLUSION: Although we did not detect improvements in disease control or overall survival for patients treated over time, the incidence of complications has significantly declined, thereby resulting in an improved therapeutic ratio for patients with carcinomas of the paranasal sinuses and nasal cavity.

Entities:  

Mesh:

Year:  2007        PMID: 17459609     DOI: 10.1016/j.ijrobp.2007.02.031

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

1.  Head and Neck Cancers, Version 1.2015.

Authors:  David G Pfister; Sharon Spencer; David M Brizel; Barbara Burtness; Paul M Busse; Jimmy J Caudell; Anthony J Cmelak; A Dimitrios Colevas; Frank Dunphy; David W Eisele; Robert L Foote; Jill Gilbert; Maura L Gillison; Robert I Haddad; Bruce H Haughey; Wesley L Hicks; Ying J Hitchcock; Antonio Jimeno; Merrill S Kies; William M Lydiatt; Ellie Maghami; Thomas McCaffrey; Loren K Mell; Bharat B Mittal; Harlan A Pinto; John A Ridge; Cristina P Rodriguez; Sandeep Samant; Jatin P Shah; Randal S Weber; Gregory T Wolf; Frank Worden; Sue S Yom; Nicole McMillian; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2015-07       Impact factor: 11.908

2.  IMRT and IGRT in head and neck cancer: Have we delivered what we promised?

Authors:  Gupta Tejpal; Agarwal Jaiprakash; Bannerjee Susovan; Sarbani Ghosh-Laskar; Vedang Murthy; Ashwini Budrukkar
Journal:  Indian J Surg Oncol       Date:  2010-11-21

3.  Craniofacial Resection for Sinonasal Malignant Tumors: Statistical Analysis of Surgical Outcome over 17 Years at a Single Institution.

Authors:  Seiichiro Mine; Naokatsu Saeki; Kentaro Horiguchi; Toyoyuki Hanazawa; Yoshitaka Okamoto
Journal:  Skull Base       Date:  2011-07

Review 4.  Proton beam radiation therapy for head and neck malignancies.

Authors:  Steven J Frank; Ugur Selek
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

5.  Comparative outcome of surgical and nonsurgical therapy for T4bN0M0 sinonasal squamous cell carcinomas.

Authors:  Ruichen Li; Shu Tian; Lan Lin; Quan Liu; Shengzi Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-26       Impact factor: 2.503

6.  Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.

Authors:  Ming Fan; Jung Julie Kang; Anna Lee; Dan Fan; Huili Wang; Sarin Kitpanit; Pamela Fox; Kevin Sine; Dennis Mah; Sean M McBride; Chiaojung Jillian Tsai; Nadeem Riaz; Lara A Dunn; Eric J Sherman; Loren Michel; Bhuvanesh Singh; Ian Ganly; Richard J Wong; Jay O Boyle; Marc A Cohen; Nancy Y Lee
Journal:  Cancer       Date:  2020-02-25       Impact factor: 6.860

7.  Management of sinonasal tumors: prognostic factors and outcomes: a 10 year experience at a tertiary care hospital.

Authors:  Maliha Kazi; Sohail Awan; Montasir Junaid; Sadaf Qadeer; Nabeel Humayun Hassan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-04-07

Review 8.  New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.

Authors:  Nancy Y Lee; Quynh-Thu Le
Journal:  Semin Oncol       Date:  2008-06       Impact factor: 4.929

9.  Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases.

Authors:  Lester D R Thompson; Carla Penner; Ngoc J Ho; Robert D Foss; Markku Miettinen; Jacqueline A Wieneke; Christopher A Moskaluk; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2013-09-15

Review 10.  Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis.

Authors:  Bijan Khademi; Azadeh Moradi; Sara Hoseini; Mohammad Mohammadianpanah
Journal:  Oral Maxillofac Surg       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.